Stephanie Moran

Title: Stephanie Moran: Innovator in Diabetes Treatment

Introduction

Stephanie Moran is a prominent inventor based in Princeton, NJ (US). She has made significant contributions to the field of diabetes treatment, particularly focusing on patients with extreme insulin resistance. Her innovative approach has the potential to improve the lives of many individuals suffering from type 2 diabetes.

Latest Patents

Stephanie holds a patent for her invention titled "Methods for treating extreme insulin resistance in patients resistant to previous treatment with other anti-diabetic drugs employing an SGLT2 inhibitor and compositions thereof." This patent outlines methods for treating patients with type 2 diabetes who have not responded to previous treatments. The invention includes administering a therapeutically effective amount of an SGLT2 inhibitor, either alone or in combination with other anti-diabetic agents. Additionally, it provides a pharmaceutical composition containing dapagliflozin or its solvate along with other therapeutic agents.

Career Highlights

Stephanie is currently associated with Bristol-Myers Squibb Company, where she continues to work on innovative solutions for diabetes management. Her dedication to research and development has positioned her as a key player in the pharmaceutical industry.

Collaborations

Some of her notable coworkers include Paul Strumph and James F List, who collaborate with her on various projects aimed at advancing diabetes treatment.

Conclusion

Stephanie Moran's work in developing new methods for treating diabetes showcases her commitment to improving patient outcomes. Her innovative patent and collaboration with leading professionals in the field highlight her significant contributions to medical science.